- Trials with a EudraCT protocol (21)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
21 result(s) found for: Indican.
Displaying page 1 of 2.
EudraCT Number: 2009-017829-19 | Sponsor Protocol Number: LFNK | Start Date*: 2011-01-18 |
Sponsor Name:Instituto Científico y Tecnológico de Navarra | ||
Full Title: Ensayo clínico fase II controlado de inmunoterapia combinada con linfocitos efectores autólogos en pacientes con linfoma no Hodgkin folicular en tratamiento de mantenimiento con rituximab tras resp... | ||
Medical condition: Linfoma no Hodgkin folicular | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-013554-32 | Sponsor Protocol Number: CeTMAd/ICC/2009 | Start Date*: 2010-04-15 |
Sponsor Name:Fundación Progreso y Salud | ||
Full Title: ENSAYO CLÍNICO FASE I/II MULTICÉNTRICO, ABIERTO Y ALEATORIZADO PARA EL ESTUDIO DEL USO DE LAS CÉLULAS TRONCALES MESENQUIMALES DE TEJIDO ADIPOSO (CeTMAd) COMO TERAPIA DE REGENERACIÓN CELULAR EN EL S... | ||
Medical condition: Pacientes no diabéticos con isquemia crónica crítica de miembros inferiores y sin posibilidad de vascularización | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-006601-25 | Sponsor Protocol Number: ZAR2007 | Start Date*: 2008-03-06 |
Sponsor Name:FUNDACION PETHEMA | ||
Full Title: Estudio abierto, multicéntrico, aleatorizado en fase II, para evaluar la eficacia de tratamiento tras la respuesta terapéutica inicial al régimen R-CHOP en pacientes con linfoma folicular no tratad... | ||
Medical condition: Linfoma folicular en pacientes no tratados previamente | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-019939-35 | Sponsor Protocol Number: Metocard | Start Date*: 2010-08-03 | |||||||||||
Sponsor Name:CNIC Centro Nacional de Investigaciones Cardiológicas | |||||||||||||
Full Title: Daño por isquémia-reperfusión: nuevos datos en el conocimiento de los mecanismos de acción responsables de la cardioprotección conferida por el B-bloqueo en el infarto agudo de miocardio.Traslación... | |||||||||||||
Medical condition: Comparar el efecto de dos regímenes de inicio de metoprolol en pacientes con infarto de miocardio (intravenoso versus oral) en el tamaño de infarto, función cardiaca y eventos cardiovasculares. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002694-13 | Sponsor Protocol Number: COMBOKA-07 | Start Date*: 2009-06-18 | |||||||||||
Sponsor Name:Fundación Biomédica del CHUVI | |||||||||||||
Full Title: Estudio piloto, fase IV para analizar la seguridad de los combos Truvada vs Kivexa como parte de un TARGA basado en Kaletra. Estudio COMBOKA | |||||||||||||
Medical condition: Paciente infectado por el VIH sin tratamiento antirretroviral previo | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001542-57 | Sponsor Protocol Number: PI0428/2007 | Start Date*: 2008-11-05 | |||||||||||
Sponsor Name:Manuel García Medina | |||||||||||||
Full Title: EFECTIVIDAD DE LA SUPLEMENTACIÓN ANTIOXIDANTE PARA PREVENIR LA PROGRESIÓN CLÍNICA EN EL GLAUCOMA | |||||||||||||
Medical condition: Efecto neuroprotector de los suplementos vitamínicos en el glaucoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005256-33 | Sponsor Protocol Number: 1182.107 | Start Date*: 2007-09-14 | |||||||||||
Sponsor Name:Boehringer Ingelheim España, S.A. | |||||||||||||
Full Title: Ensayo clínico multicéntrico, aleatorizado y abierto para evaluar tres dosis de Tipranavir potenciado con dosis bajas de ritonavir (500mg/200mg una vez al día, 250mg/100 mg dos veces al día y 500 m... | |||||||||||||
Medical condition: Los pacientes de este estudio deben ser varones y mujeres con edades comprendidas entre los 18 y los 65 años de edad infectados por VIH-1 y no tratados anteriormente con antirretrovirales. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-024099-25 | Sponsor Protocol Number: MO22982 | Start Date*: 2011-09-21 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
Full Title: A randomized, multi-center cross-over study to evaluate patient preference and Health Care Professional (HCP) satisfaction with subcutaneous (SC) administration of trastuzumab in HER2-positive earl... | |||||||||||||
Medical condition: Cáncer de mama precoz HER2 positivo | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) SE (Completed) GB (Completed) DK (Completed) DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001922-28 | Sponsor Protocol Number: A7941005 | Start Date*: 2007-08-07 | |||||||||||
Sponsor Name:Pfizer Inc., 235 East 42nd Street, New York, NY 10017 | |||||||||||||
Full Title: A Phase 2A, Randomized, Placebo-controlled, Parallel group, Multiple-dose study to evaluate the Efficacy, Safety and Tolerability of 12-week oral administration of PF-00734200 tablets to subjects w... | |||||||||||||
Medical condition: Type 2 Diabetes Mellitus (T2DM) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) ES (Completed) IT (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003443-31 | Sponsor Protocol Number: D8480C00041 | Start Date*: 2006-04-19 |
Sponsor Name:AstraZeneca AB | ||
Full Title: A Phase II, Double-blind, Randomized Study to Compare the Efficacy of AZD2171 in Combination with 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX) and the Efficacy of Bevacizumab in Combination... | ||
Medical condition: Metastatic colorectal cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) AT (Completed) DE (Completed) CZ (Completed) ES (Completed) BE (Completed) SK (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-013223-37 | Sponsor Protocol Number: A9391005 | Start Date*: 2009-11-10 | |||||||||||
Sponsor Name:Pfizer Inc. | |||||||||||||
Full Title: A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, ACTIVE AND PLACEBO CONTROLLED STUDY OF PF-04171327 IN THE TREATMENT OF THE SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS | |||||||||||||
Medical condition: Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) HU (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005855-16 | Sponsor Protocol Number: NKT102552 | Start Date*: 2006-03-20 |
Sponsor Name:GlaxoSmithKline Research and Development Ltd | ||
Full Title: A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for... | ||
Medical condition: Postoperative Nausea and Vomiting (PONV) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: BE (Completed) HU (Completed) ES (Completed) CZ (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-002519-28 | Sponsor Protocol Number: F3Z-MC-IOOX | Start Date*: 2006-10-01 |
Sponsor Name:Lilly S.A. | ||
Full Title: Ensayo PRIME DT2: Regímenes prandiales-basales de Insulina para mejorar la glucemia post-pandrial en Diabetes Tipo 2.Comparación de dos enfoques con terapia basal y en bolo en pacientes con Diabete... | ||
Medical condition: Diabetes tipo II | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) GR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-003800-73 | Sponsor Protocol Number: 12011-201 | Start Date*: 2009-07-14 | |||||||||||
Sponsor Name:PARI Pharma GmbH | |||||||||||||
Full Title: A phase II, multicentre, randomised, double-blind, placebo controlled clinical trial to investigate the efficacy and safety of 10 or 20 mg/day aerosolised liposomal ciclosporin A (L-CsA) versus aer... | |||||||||||||
Medical condition: Prevention of bronchiolitis obliterans syndrome in lung transplant | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) GB (Prematurely Ended) BE (Prematurely Ended) AT (Prematurely Ended) DK (Prematurely Ended) ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019867-13 | Sponsor Protocol Number: 8669-041 | Start Date*: 2010-08-12 |
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | ||
Full Title: "Ensayo aleatorizado, de adaptación y con dos partes de ridaforolimus combinado con dalotuzumab en comparación con exemestano o en comparación con ridaforolimus o dalotuzumab en monoterapia en paci... | ||
Medical condition: Pacientes con cáncer de mama positivo para receptores estrogénicos (RE) /Patients with breast cancer estrogen receptor positive (ER) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: ES (Completed) DE (Completed) IE (Completed) BE (Completed) DK (Completed) SE (Completed) FR (Completed) IT (Completed) GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2010-020033-14 | Sponsor Protocol Number: CDEB025A2210 | Start Date*: 2010-09-03 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A multicentre, randomized, double-blind, placebocontrolled, parallel-group phase II study on efficacy and safety of DEB025 combined with peg-IFN alfa-2a and ribavirin in chronic hepatitis C genotyp... | |||||||||||||
Medical condition: Chronic Hepatitis C Genotype 1 patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) HU (Completed) DE (Completed) FR (Completed) ES (Completed) BE (Completed) IT (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-014834-22 | Sponsor Protocol Number: CAIN457C2302 | Start Date*: 2010-07-06 | |||||||||||||||||||||
Sponsor Name:Novartis Farmacéutica, S.A. | |||||||||||||||||||||||
Full Title: Estudio Fase III, multicéntrico, aleatorizado con doble enmascaramiento, controlado con placebo, de determinación de dosis y 28 semanas de duración, para evaluar AIN457 frente a placebo en la induc... | |||||||||||||||||||||||
Medical condition: determinación de dosis y 28 semanas de duración, para evaluar AIN457 frente a placebo en la inducción y mantenimiento de la supresión de la uveítis en adultos con uveítis activa no infecciosa inter... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Prematurely Ended) HU (Prematurely Ended) GB (Completed) DE (Prematurely Ended) FR (Prematurely Ended) IT (Prematurely Ended) GR (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-000800-17 | Sponsor Protocol Number: TDE-PH-301 | Start Date*: 2007-02-15 | |||||||||||
Sponsor Name:United Therapeutics Corporation | |||||||||||||
Full Title: A 16-Week International, Multicenter, Double-Blind, Randomized, Placebo Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Combination with an Endothelin... | |||||||||||||
Medical condition: Idiopathic or Familial pulmonary arterial hypertension (PAH), including PAH associated with: 1) Appetite suppressant use, or 2) Repaired congenital systemic-to-pulmonary shunts (repaired ≥ 5 yea... | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) GB (Completed) NL (Completed) AT (Completed) FR (Completed) BE (Completed) IT (Completed) DE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-018646-31 | Sponsor Protocol Number: CT-P13-3.1 | Start Date*: 2010-10-11 | ||||||||||||||||
Sponsor Name:CELLTRION, Inc | ||||||||||||||||||
Full Title: A Randomized, Double Blind, Parallel-Group, Phase 3 Study to Demonstrate Equivalence in Efficacy and Safety of CT-P13 Compared With Remicade When Co-administered With Methotrexate in Patients With ... | ||||||||||||||||||
Medical condition: Rheumatoid Arthritis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SK (Completed) LV (Completed) GB (Completed) PT (Completed) IT (Completed) AT (Completed) LT (Completed) ES (Completed) BG (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-021297-11 | Sponsor Protocol Number: I4T-MC-JVBA | Start Date*: 2011-03-07 | |||||||||||
Sponsor Name:Eli Lilly and Company Limited, Indianapolis | |||||||||||||
Full Title: A Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer Following Disease Progression after One P... | |||||||||||||
Medical condition: Stage IV Non-Small Cell Lung Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) NL (Completed) ES (Completed) IT (Completed) NO (Completed) AT (Completed) SE (Completed) GR (Completed) GB (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
